Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes.
Saved in:
| Title: | Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes. |
|---|---|
| Authors: | Lyu, Young Sang1 (AUTHOR) lyu0923@chosun.ac.kr, Lee, Hansol2 (AUTHOR) hslee110@daewoong.co.kr, Kim, Kyung-Soo3 (AUTHOR) kks982@hanmail.net, Hong, Sangmo4 (AUTHOR) lanugo35@gmail.com, Park, Cheol-Young5 (AUTHOR) cydoctor@skku.edu |
| Source: | Cardiovascular Diabetology. 8/31/2025, Vol. 24 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
